Craig Lipset is Head of Clinical Innovation, Development Operations within Worldwide Research & Development at Pfizer. In this new role, Craig is working across units and stakeholders to define Pfizer’s vision for the future of clinical trials, and enabling the initiatives and investments to create that future. Most recently, Craig served as Venture Partner in Pfizer Venture Investments (Pfizer's VC arm), where he focused on diversifying the company's $50M annual budget for private investments in the areas of diagnostics and health technology. Craig was also Senior Director in Molecular Medicine, where he spearheaded initiatives driving innovation in clinical research and personalized medicines by drawing upon tools from health information technology, telemedicine, and eHealth.

Craig brings over 15 years of leadership and innovation...

Motivated, intelligent, analytical, and talented individual. Demonstrated leadership in developing information systems that meet challenging and complex business needs.

Extensive experience in manufacturing operations and business processes at both site and headquarters levels. In essence, there are three themes running throughout my career:

1. leading change
2. building information systems for inventory and supply chain management, and
3. the management of sterile antibiotics supporting >$600 million in sales worldwide.

Suzanne joined Bayer Healthcare (then Miles Laboratories) over 20 years ago as a Research Scientist working in their core Oligonucleotide Facility and later performing Osteoarthritis Research as a Molecular Biologist.

Throughout the years, she transitioned to clinical research where she was a CRA road-warrior as well as a Project Manager for Bayer's Anti-infective Pharmaceutical division.

After receiving her MBA, she was asked to lead the External Supplier Management group where she handled the U.S. clinical outsourcing and contracting of various clinical research services.

Today, she is the Alliance Manager for R&D Services, Bayer Healthcare Procurement.

Nancy started her career as a Chiropractic Physician with a private practice in Denver, Colorado.

After founding and running a Chiropractic temporary employment agency in the NY, NJ and CT area for eight years, she moved to Pfizer.

At Pfizer, Nancy has held positions of increasing responsibility and has more than 13 years experience as a learning professional and is an internationally recognized speaker on eLearning, blended learning and learning strategies.

Nancy was instrumental in the introduction of eLearning to Pfizer and holds a Masters Degree in Distance Education from the University of Maryland University College, Graduate School of Management and Technology.

A highly accomplished professional she has expertise in diverse areas of development, education and training. Dr. Grey's eLearning...

Ken received his Ph.D. from the University of Utah in 1996 and came to Lilly in 1998 from the Memorial Sloan Kettering Cancer Research Center as an Organic Chemist.

He worked on several projects as a medicinal chemist in the areas of anxiety, depression and inflammatory disorders, and he has been involved in many cross-functional Lilly research collaborations.

In the fall of 2004 Ken went into the Lean-Six Sigma program at Lilly and led ten projects as a 6-Sigma Black Belt before moving back to chemistry as the Head of the Global Operations for Discovery Chemistry Research and Technology.

In 2008, Ken took on new a new role as a Head in Drug Disposition with responsibilities across the in-vitro, Transporter...

Larry has over twenty years’ experience in pharmaceutical and biotechnology drug development.
He received his Bachelor of Science degree from Rutgers University and his Ph.D. degree in Biology from Wesleyan University in Middletown, CT.

He completed four years of post-doctoral research as a Leukemia Society of America Fellow at Tufts Medical School in Boston, MA., where his research examined genetic regulatory mechanisms involved in the transformation of normal cells to a neoplastic state.

Prior to joining Genzyme as a Senior Director of Clinical Research in 2002 he was an Executive Director of Program Management at Quintiles responsible for global clinical development in their oncology franchise.

Dr. Blankstein has held positions as Manager of Immunodiagnostics...

Mike Capaldi is Associate Vice President, North American Corporate Social Responsibility & Institutional Relations for Sanofi-aventis US. Mike is based in the Bridgewater, NJ US headquarters and is in his 15th year with the organization.

He is responsible for establishing relationships within the Healthcare community to advance platforms such as Care Coordination and Prevention & Wellness. In addition, Mike is working collaboratively with PhRMA to support key strategic platforms.

Prior to his current role, Mike was the Head of Commercial Training & Development and was responsible for the training of nearly 10,000 field and headquarter-based employees.

Involved in Training & Development for over 12 years, Mike is also President of the Society of Pharmaceutical and Biotech Trainers and a member of ASTD. In 2007...